Denosumab--an emerging treatment for postmenopausal osteoporosis.
about
Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumabReceptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone lossOsteonecrosis of the jaw in patients treated with denosumab for metastatic tumors to the bone: A series of thirteen patients.Models and screening assays for drug discovery in osteoporosis.
P2860
Denosumab--an emerging treatment for postmenopausal osteoporosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Denosumab--an emerging treatment for postmenopausal osteoporosis.
@en
Denosumab--an emerging treatment for postmenopausal osteoporosis.
@nl
type
label
Denosumab--an emerging treatment for postmenopausal osteoporosis.
@en
Denosumab--an emerging treatment for postmenopausal osteoporosis.
@nl
prefLabel
Denosumab--an emerging treatment for postmenopausal osteoporosis.
@en
Denosumab--an emerging treatment for postmenopausal osteoporosis.
@nl
P2860
P1476
Denosumab--an emerging treatment for postmenopausal osteoporosis.
@en
P2093
E Michael Lewiecki
P2860
P304
P356
10.1517/14712591003604708
P407
P577
2010-03-01T00:00:00Z